Voya Investment Management LLC Vbi Vaccines Inc Transaction History

Voya Investment Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.38 - $22.5 $8,293 - $491,040	21,824 Added 29.65%	95,428 $37,000
Q3 2022 Mar 03, 2023	SELL	$0.73 - $23.4 $15,931 - $510,681	-21,824 Reduced 22.87%	73,604 $53,000
Q4 2021 Feb 14, 2022	SELL	$2.21 - $3.22 $6,238 - $9,090	-2,823 Reduced 3.69%	73,604 $172,000
Q2 2021 Aug 16, 2021	SELL	$2.61 - $4.17 $9,677 - $15,462	-3,708 Reduced 4.63%	76,427 $256,000
Q1 2021 May 17, 2021	BUY	$2.91 - $4.32 $9,352 - $13,884	3,214 Added 4.18%	80,135 $249,000
Q4 2020 Feb 16, 2021	BUY	$2.15 - $3.5 $37,121 - $60,431	17,266 Added 28.94%	76,921 $212,000
Q2 2020 Aug 14, 2020	SELL	$0.87 - $3.13 $12,842 - $46,201	-14,761 Reduced 19.84%	59,655 $185,000
Q4 2019 Feb 14, 2020	BUY	$0.48 - $1.38 $12,517 - $35,987	26,078 Added 53.95%	74,416 $103,000
Q2 2019 Aug 14, 2019	BUY	$0.65 - $2.12 $31,419 - $102,476	48,338 New	48,338 $57,000
Q2 2018 Aug 14, 2018	SELL	$2.75 - $3.85 $50,767 - $71,074	-18,461 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$3.5 - $4.47 $15,452 - $19,735	-4,415 Reduced 19.3%	18,461 $65,000
Q4 2017 Feb 14, 2018	BUY	$3.29 - $5.03 $75,262 - $115,066	22,876	22,876 $98,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.